Skip to Content


In the US, Dexrazoxane (dexrazoxane systemic) is a member of the drug class miscellaneous uncategorized agents and is used to treat Cardiomyopathy Prophylaxis and Extravasation.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category


Chemical Names

(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione (WHO)

(S)-4,4'-(Propan-1,2-diyl)bis(piperazin-2,6-dion) (IUPAC)

Foreign Names

  • Dexrazoxanum (Latin)
  • Dexrazoxan (German)
  • Dexrazoxane (French)
  • Dexrazoxane (Spanish)

Generic Names

Brand Names

  • Ao Nuo Xian
    AosaiKang Pharmaceutical, China
  • Cardioxane
    Chiron, Egypt; Clinigen, Poland; Medicamenta Ecuatoriana, Ecuador; Nolver, Venezuela; Novartis, Czech Republic; Novartis, Greece; Novartis, Lebanon; Novartis, Lithuania
  • Cyrdanax
    Pharmaselect, Poland; Pharmaselect, Slovakia
  • Dexrazoxane
    Raffo, Argentina
  • Savene
    Clinigen, Poland; Norgine, Greece; SpePharm, Portugal; SpePharm, Lithuania
  • Zinecard
    Pfizer, Canada
  • Cardioxane
    Asofarma de Mexico, Mexico; Clinigen, Netherlands; Clinigen Healthcare, United Kingdom; Grupo Novartis, Spain; Novartis, France; Novartis, Israel; Novartis Farma, Italy
  • Cyrdanax
    medac, France; Pharmaselect, Austria
  • Dexarazoxane Martian
    LKM, Argentina
  • Savene
    Clinigen, Belgium; Clinigen Healthcare, United Kingdom; Ferrer Internacional, Spain; Norgine, Austria; Norgine, Germany; Norgine, France; SpePharm, Denmark; SpePharm, Netherlands; SpePharm, Norway; SpePharm Italia, Italy
  • Totect
    Topotarget USA, United States
  • Zinecard
    Pharmacia & Upjohn, United States


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.